July 23, 2015
GlaxoSmithKline LLC on Wednesday was hit with a complaint in California federal court tying alleged off-label promotion of anti-nausea drug Zofran to birth defects, adding to a number of similar lawsuits that have emerged this year and appear headed for multidistrict litigation.